Breast Cancer Trial, Recruiting NCT07474337 Sponsor: Firat University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07474337
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older
  • People who have been told their breast cancer diagnosis and are aware of it
  • People who are receiving chemotherapy for the first time as part of breast cancer treatment
  • People diagnosed with stage I, II, or III breast cancer
  • People who are not currently being treated for another type of cancer
  • People who do not have a hearing or speech difficulty that would make phone interviews difficult
  • People who do not have a psychiatric condition that would affect their ability to understand information
  • People who have agreed to take part in the study both verbally and in writing

Who may not be able to join:

  • People diagnosed with stage IV (metastatic) breast cancer
  • People who are also being treated for a separate cancer
  • People with a hearing or speech difficulty that would prevent participation in telephone interviews
  • People with a psychiatric condition that affects their ability to understand or communicate
  • People who have difficulty communicating for any reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Firat University
Registry
ClinicalTrials.gov
Start date
10 March 2026
Est. completion
15 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Symptom Severity

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov